SimBioSys takes in $15m Series A
Chicago-based SimBioSys, a simulation-based, precision medicine platform, has raised $15 million in Series A funding.
Chicago-based SimBioSys, a simulation-based, precision medicine platform, has raised $15 million in Series A funding.